Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Oct-23 5:01 PM View:  | Crinetics Pharmaceuticals, ... (CRNX) | 17-Oct-23 | Option Exercise | 7,000 | $12.01 | $84,070.00 | 16% 43.21K to 50.21K | |
| 19-Oct-23 5:01 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 17-Oct-23 | Option Sale | 7,000 | $30.00 | $210,000.00 | (14%) 50.21K to 43.21K | |
| 17-Mar-23 5:09 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 16-Mar-23 | Payment of Exercise | 1,687 | $17.12 | $28,881.40 | (4%) 43.99K to 42.3K | |
| 03-Mar-23 4:43 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Mar-23 | Grant | 19,500 | -- | -- | 80% 24.49K to 43.99K | |
| 27-Jan-23 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Nov-22 | Acquisition (other) | 712 | $11.02 | $7,846.24 | 3% 23.78K to 24.49K | |
| 27-Jan-23 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-May-22 | Acquisition (other) | 1,215 | $11.02 | $13,389.30 | 5% 22.56K to 23.78K | |
| 02-Mar-22 9:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 28-Feb-22 | Grant | 14,250 | -- | -- | 171% 8.31K to 22.56K | |
| 21-Jan-22 4:54 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 19-Jan-22 | Option Exercise | 6,700 | $12.01 | $80,467.00 | 81% 8.31K to 15.01K | |
| 21-Jan-22 4:54 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 19-Jan-22 | Planned Option Sale | 6,700 | $21.21 | $142,080.00 | (45%) 15.01K to 8.31K | |
| 05-Feb-21 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Nov-20 | Acquisition (other) | 277 | $11.61 | $3,215.97 | 5% 6.11K to 6.38K | |
| 05-Feb-21 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-May-20 | Acquisition (other) | 1,165 | $14.45 | $16,834.20 | 24% 4.94K to 6.11K | |
| 11-Feb-20 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-May-19 | Acquisition (other) | 1,471 | $14.45 | $21,255.90 | 42% 3.47K to 4.94K | |
| 12-Feb-19 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Nov-18 | Acquisition (other) | 1,470 | $14.45 | $21,241.50 | 74% 2.0K to 3.47K | |
| 20-Jul-18 4:06 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Jul-18 | Purchase | 2,000 | $17.00 | $34,000.00 | 100% 0 to 2.0K | |
| 14-Mar-14 4:02 PM View: | Biodel Inc. (ALBO) | 12-Mar-14 | Payment of Exercise | 1,843 | -- | -- | (5%) 37.53K to 35.69K | |
| 14-Mar-14 4:02 PM View: | Biodel Inc. (ALBO) | 12-Mar-14 | Option Exercise | 6,026 | -- | -- | 19% 31.5K to 37.53K | |
| 14-Mar-13 5:10 PM View: | Biodel Inc. (ALBO) | 12-Mar-13 | Payment of Exercise | 1,854 | -- | -- | (6%) 33.36K to 31.5K | |
| 14-Mar-13 5:10 PM View: | Biodel Inc. (ALBO) | 12-Mar-13 | Option Exercise | 6,024 | -- | -- | 22% 27.33K to 33.36K | |
| 05-Nov-12 5:20 PM View: | Biodel Inc. (ALBO) | 02-Nov-12 | Market Sale (Planned) | 1,100 | $2.78 | $3,058.00 | (4%) 28.43K to 27.33K | 77% |
| 05-Nov-12 5:20 PM View: | Biodel Inc. (ALBO) | 01-Nov-12 | Market Sale (Planned) | 2,400 | $2.82 | $6,768.00 | (8%) 30.83K to 28.43K | 78% |
| 02-Oct-12 8:04 PM View: | Biodel Inc. (ALBO) | 30-Sep-12 | Payment of Exercise | 8,323 | $2.87 | $23,887.00 | (21%) 39.16K to 30.83K | 78% |
| 02-Oct-12 8:04 PM View: | Biodel Inc. (ALBO) | 30-Sep-12 | Option Exercise | 27,296 | -- | -- | 230% 11.86K to 39.16K | |
| 14-Mar-12 4:27 PM View: | Biodel Inc. (ALBO) | 12-Mar-12 | Option Exercise | 35,350 | -- | -- | 292% 12.1K to 47.45K | |
| 22-Sep-11 11:27 AM View: | Biodel Inc. (ALBO) | 20-Sep-11 | Market Sale | 3,855 | $1.17 | $4,510.35 | (24%) 15.95K to 12.1K | 87% |
| 10-Feb-11 5:25 PM View: | Biodel Inc. (ALBO) | 08-Feb-11 | Option Exercise | 12,850 | -- | -- | 415% 3.1K to 15.95K | |
| 12-Nov-09 9:54 AM View: | Biodel Inc. (ALBO) | 09-Nov-09 | Option Exercise | 3,100 | $1.94 | $6,014.00 | 100% 0 to 3.1K |